Average Co-Inventor Count = 4.37
ph-index = 24
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Incyte Corporation (110 from 665 patents)
2. Incyte Holdings Corporation (6 from 147 patents)
110 patents:
1. 12466822 - Heterocyclic compounds as immunomodulators
2. 12441731 - Pyrazolopyrimidine compounds and uses thereof
3. 12312331 - Imidazolyl pyrimidinylamine compounds as CDK2 inhibitors
4. 12247026 - Heterocyclic compounds as immunomodulators
5. 12247038 - Pyrido[3,2-d]pyrimidine compounds as immunomodulators
6. 12187743 - Heterocyclic compounds as immunomodulators
7. 12187725 - Tricyclic urea compounds as JAK2 V617F inhibitors
8. 12129267 - Heteroaryl amide compounds as sting activators
9. 12060433 - CD73 inhibitor and A2A/A2B adenosine receptor inhibitor combination therapy
10. 12030889 - Imidazopyridazine and imidazopyridine compounds and uses thereof
11. 11999740 - Fused pyrazine derivatives as A2A / A2B inhibitors
12. 11981671 - Bicyclic pyrazolyl amines as CDK2 inhibitors
13. 11958861 - Spirocyclic lactams as JAK2 V617F inhibitors
14. 11919908 - Substituted pyrrolo[2,3-d]pyrimidine compounds as JAK2 V617F inhibitors
15. 11919904 - Sulfonylamide compounds as CDK2 inhibitors